Trial Profile

A Phase 1 investigator-sponsored clinical trial to evaluate MB-106 for the treatment of autoimmune diseases

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 03 Apr 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MB-106 (Primary)
Indications Autoimmune disorders
Focus Adverse reactions; Proof of concept

Most Recent Events

03 Apr 2024 New trial record
28 Mar 2024 According to a Mustang Bio media release, the Mustang and Fred Hutch are in preliminary discussions to explore MB-106 to determine the autoimmune indication(s) and are planning is underway for this trial and expected to enroll first patient in the fourth quarter of 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com